Literature DB >> 8254770

Nucleotide sequence of wild-type hepatitis A virus GBM in comparison with two cell culture-adapted variants.

J Graff1, A Normann, S M Feinstone, B Flehmig.   

Abstract

In order to study cell tropism and attenuation of hepatitis A virus (HAV), the genome of HAV wild-type GBM and two cell culture-adapted variants, GBM/FRhK and GBM/HFS, were cloned and sequenced after amplification by reverse transcriptase-PCR. During virus cultivation, the HAV variant GBM/FRhK had a strict host range for FRhK-4 cells, in contrast to GBM/HFS, which can be grown in HFS and FRhK-4 cells. The HAV variant GBM/HFS was shown to be attenuated when inoculated into chimpanzees (B. Flehmig, R. F. Mauler, G. Noll, E. Weinmann, and J. P. Gregerson, p. 87-90, in A. Zuckerman, ed., Viral Hepatitis and Liver Disease, 1988). On the basis of this biological background, the comparison of the nucleotide sequences of these three HAV GBM variants should elucidate differences which may be of importance for cell tropism and attenuation. The comparison of the genome between the GBM wild type and HAV wild types HM175 (J. I. Cohen, J. R. Ticehurst, R. H. Purcell, A. Buckler-White, and B. M. Baroudy, J. Virol. 61:50-59, 1987) and HAV-LA (R. Najarian, O. Caput, W. Gee, S. J. Potter, A. Renard, J. Merryweather, G. Van Nest, and D. Dina, Proc. Natl. Acad. Sci. USA 82:2627-2631, 1985) showed a 92 to 96.3% identity, whereas the identity was 99.3 to 99.6% between the GBM variants. Nucleotide differences between the wild-type and the cell culture-adapted variants, which were identical in both cell culture-adapted GBM variants, were localized in the 5' noncoding region; in 2B, 3B, and 3D; and in the 3' noncoding region. Our result concerning the 2B/2C region confirms a mutation at position 3889 (C-->T, alanine to valine), which had been shown to be of importance for cell culture adaptation (S. U. Emerson, C. McRill, B. Rosenblum, S. M. Feinstone, and R. H. Purcell, J. Virol. 65:4882-4886, 1991; S. U. Emerson, Y. K. Huang, C. McRill, M. Lewis, and R. H. Purcell, J. Virol. 66:650-654, 1992), whereas other mutations differ from published HAV sequence data and may be cell specific. Further comparison of the two cell culture-adapted GBM variants showed cell-specific mutations resulting in deletions of six amino acids in the VP1 region and three amino acids in the 3A region of the GBM variant GBM/FRhK.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254770      PMCID: PMC236320     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Properties of a hepatitis A virus candidate vaccine strain.

Authors:  U Heinricy; Y D Stierhof; M Pfisterer; B Flehmig
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

2.  Antigenic and genetic variation in cytopathic hepatitis A virus variants arising during persistent infection: evidence for genetic recombination.

Authors:  S M Lemon; P C Murphy; P A Shields; L H Ping; S M Feinstone; T Cromeans; R W Jansen
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

3.  Mutations responsible for adaptation of hepatitis A virus to efficient growth in cell culture.

Authors:  S U Emerson; C McRill; B Rosenblum; S Feinstone; R H Purcell
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

4.  Nucleotide sequence of high-passage hepatitis A virus strain HM175: comparison with wild-type and cell culture-adapted strains.

Authors:  B C Ross; B N Anderson; P C Edwards; I D Gust
Journal:  J Gen Virol       Date:  1989-10       Impact factor: 3.891

5.  Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.

Authors:  B Flehmig; U Heinricy; M Pfisterer
Journal:  Lancet       Date:  1989-05-13       Impact factor: 79.321

6.  Primary structure and gene organization of human hepatitis A virus.

Authors:  R Najarian; D Caput; W Gee; S J Potter; A Renard; J Merryweather; G Van Nest; D Dina
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Replicative events in hepatitis A virus-infected MRC-5 cells.

Authors:  J De Chastonay; G Siegl
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

8.  Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication.

Authors:  R W Jansen; J E Newbold; S M Lemon
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

9.  Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses.

Authors:  J I Cohen; J R Ticehurst; R H Purcell; A Buckler-White; B M Baroudy
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

10.  Replication kinetics and cytopathic effect of hepatitis A virus.

Authors:  T Cromeans; H A Fields; M D Sobsey
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

View more
  30 in total

1.  Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution.

Authors:  R M Bush; C B Smith; N J Cox; W M Fitch
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

2.  Mutational characteristics in consecutive passage of rapidly replicating variants of hepatitis A virus strain H2 during cell culture adaptation.

Authors:  Ning-Zhu Hu; Yun-Zhang Hu; Hai-Jing Shi; Guo-Dong Liu; Su Qu
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

3.  Full-length genome of wild-type hepatitis A virus (DL3) isolated in China.

Authors:  Guo-Dong Liu; Ning-Zhu Hu; Yun-Zhang Hu
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

Review 4.  Diagnosis of hepatitis a virus infection: a molecular approach.

Authors:  Omana V Nainan; Guoliang Xia; Gilberto Vaughan; Harold S Margolis
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

5.  Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient.

Authors:  Toshinori Tanaka; Masaharu Takahashi; Hideyuki Takahashi; Koji Ichiyama; Yu Hoshino; Shigeo Nagashima; Hitoshi Mizuo; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

6.  Stable growth of wild-type hepatitis A virus in cell culture.

Authors:  Krishnamurthy Konduru; Gerardo G Kaplan
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

7.  Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription.

Authors:  R L Chaves; J Graff; A Normann; B Flehmig
Journal:  Nucleic Acids Res       Date:  1994-05-25       Impact factor: 16.971

8.  Genus-specific substitution rate variability among picornaviruses.

Authors:  Allison L Hicks; Siobain Duffy
Journal:  J Virol       Date:  2011-05-25       Impact factor: 5.103

9.  A cytopathogenic, apoptosis-inducing variant of hepatitis A virus.

Authors:  K Brack; W Frings; A Dotzauer; A Vallbracht
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

Review 10.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.